Association of hypoalbuminemia and reversal of albumin-to-globulin ratio with morbidity outcome among hospitalized Lassa fever infected patients at a dedicated treatment center in Ondo state, south-western Nigeria

Background: As of this present moment, there is paucity of data on report concerning the association between hypoalbuminaemia or reversal of albumin-to-globulin ratio and morbidity outcome in Lassa fever (LF) infection as a crucial determinant prognostic-predictor factor for treatment-survival outcome. Aim: This study was designed to determine the association between hypoalbuminaemia, reversal of albumin-to-globulin ratio and morbidity outcome among confirmed LF infected patients. Methodology: This was a descriptive retrospective study involving the assessment of records of confirmed LF infected patients that were managed at the center from November 2018 to October 2019. Results: Out of 83 recruited participants with complete records, 66 (79.5%) had hypoalbuminaemia, 74 (89.2%) had reversal of albumin-to-globulin ratio. A higher mean value of total white blood cell (WBC) count was observed among patients with hypoalbuminaemia (p < 0.0001) and reversal of albumin-to-globulin ratio (p < 0.0001) when compared to patients with normal values, respectively. Also, this study showed statistically significant associations between serum albumin level versus total WBC count (p < 0.0001), acute kidney injury (AKI; p = 0.009), bleeding diathesis (p < 0.0001), and occurrence of pregnancy miscarriage (p < 0.0001). Conclusion: There is a baseline hypoalbuminaemia and reversal of albumin-to-globulin ratio among confirmed LF infected patients. Based on these findings, the serum level of albumin and albumin-to-globulin ratio at presentation may serve as simple early biomarkers to identify patients at high risk for a complicated clinical course of disease. This study also reveals that those hospitalized LF infected patients with hypoalbuminemia and/or reversal of albumin-to-globulin ratio tend to have leucocytosis and experience prolonged duration of illness.

[1]  P. Osho,et al.  The observed seasonal variation pattern and changing epidemiology of Lassa viral hemorrhagic fever disease in Ondo State, Nigeria , 2020 .

[2]  S. Okogbenin,et al.  Intradialytic complications: a poor prognostic factor among patients with lassa fever with acute kidney injury undergoing hemodialysis , 2019, Journal of The Egyptian Society of Nephrology and Transplantation.

[3]  Robert R. Wolfe,et al.  Hypoalbuminemia: Pathogenesis and Clinical Significance , 2018, JPEN. Journal of parenteral and enteral nutrition.

[4]  Anupama K Murthy,et al.  Serum Albumin-Globulin ratio reversal predicts morbidity in patients hospitalized for Influenza A(H1N1) infection. , 2018, Respiratory infections.

[5]  F. Polat,et al.  Prognostic role of preoperative albumin to globulin ratio in predicting survival of clear cell renal cell carcinoma , 2018, International braz j urol : official journal of the Brazilian Society of Urology.

[6]  Pardis C Sabeti,et al.  Clinical and laboratory predictors of Lassa fever outcome in a dedicated treatment facility in Nigeria: a retrospective, observational cohort study. , 2018, The Lancet. Infectious diseases.

[7]  P. Nsubuga,et al.  Mortality Among Confirmed Lassa Fever Cases During the 2015-2016 Outbreak in Nigeria , 2018, American journal of public health.

[8]  W. Liang,et al.  Prognostic Effect of Albumin-to-Globulin Ratio in Patients with solid tumors: A Systematic Review and Meta-analysis , 2017, Journal of Cancer.

[9]  Dongying Chen,et al.  Fetal outcomes and associated factors of adverse outcomes of pregnancy in southern Chinese women with systemic lupus erythematosus , 2017, PloS one.

[10]  E. Domínguez de Villota,et al.  Association of a low serum albumin with infection and increased mortality in critically Ill patients , 2005, Intensive Care Medicine.

[11]  N. Powe,et al.  Leukocytosis, hypoalbuminemia, and the risk for chronic kidney disease in US adults. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.